IndraLab

Statements

MTOR inhibitor inhibits BAP1. 1 / 1

| 1

reach

"Molecular subgroups of metastatic ccRCC based on PBRM1, BAP1, and KDM5C mutations could have predictive values for patients treated with VEGF or mTOR inhibitors."

27751729

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

MTOR inhibitor inhibits BAP1. 1 / 1

INDRA sources:

Databases

Reading